Propanolol

ApprovedSmall molecule

WWeill Medical College of Cornell University

Propanolol is one of 121 small molecule programs targeting Hemangioma. It is currently in Approved.

Indications

Total Trials

Active Trials

120

Competitors

Pipeline

Status by Indication[3][1]

Indication

HemangiomaActive, not recruiting

HyperthyroidismActive, not recruiting

SepsisActive, not recruiting

Post-Traumatic Stress DisorderActive, not recruiting

Biliary AtresiaActive, not recruiting

Breast CancerActive, not recruiting

HemangiomaPhase 3

Active, not recruiting

HyperthyroidismApproved

Active, not recruiting

SepsisApproved

Active, not recruiting

Post-Traumatic Stress DisorderApproved

Active, not recruiting

Biliary AtresiaPreclinical

Active, not recruiting

Breast CancerPhase 2

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Propanolol

WWeill Medical College of Cornell University

Approved

1 2

DATROWAY

Daiichi Sankyo

Preclinical

4 3

MS Contin

Merck & Co.

Preclinical

2 4

Zolymbus

AbbVie

Preclinical

1 5

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 6

Effexor

WWyeth-Lederle Vaccines

Preclinical

2 7

Vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Preclinical

1 8

Dextromethorphan Hydrobromide

Boehringer Ingelheim

Preclinical

1 9

Perflutren Lipid Microsphere

IImaRx Therapeutics

Preclinical

1 10

Diuretic

RReprieve Cardiovascular, Inc

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Propranolol2 trials

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Unknown status·IInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·N/A·NCT02484573·39 enrolled

Burn Healing and Analgesia With Propranolol

Completed·UUniversity of North Carolina, Chapel Hill·Phase 2·NCT00934947·45 enrolled

Hemangioma1 trial

Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma

Terminated·UUniversity Hospital, Montpellier·Phase 3·NCT01743885·55 enrolled

Sepsis1 trial

Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60%

Completed·CCentro Ortopedico y Quirurgico del Pie·Phase 4·NCT04538365·24 enrolled

Hyperthyroidism1 trial

Heart Rate Variability and Hyperthyroidism: Evaluation of the Short-term Effects of Propanolol

Completed·YYaounde Central Hospital·Phase 4·NCT03393728·10 enrolled

Breast Cancer1 trial

Neoadjuvant Propanolol in Breast Cancer

Terminated·TTexas Tech University Health Sciences Center, El Paso·Phase 2·NCT02596867·2 enrolled

4 more indications

Fear1 trial

Brief Intervention for OCD Fears

Withdrawn·NNew York State Psychiatric Institute·Phase 4·NCT02790710

Post-Traumatic Stress Disorder1 trial

Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder

Terminated·WWeill Medical College of Cornell University·Phase 4·NCT00648375·12 enrolled

Biliary Atresia1 trial

Primary Prophylaxis for Variceal Bleed in Biliary Atresia

Unknown status·IInstitute of Liver and Biliary Sciences, India·N/A·NCT04494763·92 enrolled

Unspecified1 trial

Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions

Completed·MMedical University of Vienna·Phase 2·NCT00431392·42 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Propanolol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propanolol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propanolol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Weill Medical College of Cornell University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: WWeill Medical College of Cornell University

Propanolol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Propranolol2 trials

Hemangioma1 trial

Sepsis1 trial

Hyperthyroidism1 trial

Breast Cancer1 trial

Fear1 trial

Post-Traumatic Stress Disorder1 trial

Biliary Atresia1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News